Overview

Full Product Details

Author:   Susanne Krege
Publisher:   Springer International Publishing AG
Imprint:   Springer International Publishing AG
Edition:   Softcover reprint of the original 1st ed. 2015
Weight:   2.554kg
ISBN:  

9783319359632

ISBN 10:   3319359630
Pages:   135
Publication Date:   12 October 2016
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group.- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI?.- Is there still an indication for diagnostic RPLND in nonseminoma CSI?.- How could the prognosis of patients with intermediate risk disease be improved?.- How should patients with poor-prognosis disease be treated actually?.- How should patients with recurrent disease be treated actually?.- How important are prognostic factors for determining treatment in patients with primary or recurrent disease?.- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma?.- How should residual disease outside the retroperitoneum be treated?.- What are the recent recommendations for follow up in testicular cancer?.- What are the long-term toxicities to be controlled and treated?.- Consequences of the disease and its treatment concerning sexuality and fertility.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions